Home FEATURED NEWS NASSCOM-Zinnov India GCC – Quarterly Analysis Q3 2022

NASSCOM-Zinnov India GCC – Quarterly Analysis Q3 2022

0

[ad_1]

India’s Global Capability Centers (GCCs) are driving immense worth when it comes to product innovation, for his or her HQs, and are additionally performing as sandboxes for a lot of glocal initiatives. Many Indian GCCs or GCoEs (Global Centers of Excellence) have a seat on the international desk, firmly establishing their criticality within the international group’s progress trajectory.

DOWNLOAD THE GCC TRENDS QUARTERLY ANALYSIS FOR Q3 2022

Currently, the Indian GCC market dimension is round a staggering USD 36 Bn, which continues to develop at a ten.5% CAGR. In Q3 of 2022 alone, 15 new Global Capability Centers had been arrange by firms together with IBM and Thoughtworks. Out of those, 9 belonged to the Software & Internet vertical.

In this quarter’s replace of the Zinnov-NASSCOM India GCC ecosystem, we positioned our magnifying lens on the Health and Pharmaceuticals trade. Global firms, notably American origin ones on this house, are particularly interested in Bangalore, NCR, Mumbai, and Hyderabad – be it due to the supply of expert expertise, ease of doing enterprise, or the dynamic assist ecosystem which are established in these cities.

Post the COVID-19 pandemic, the Health and Pharmaceuticals industries weren’t solely pressured to relook on the approach they functioned, however additionally they needed to take measures to enhance effectivity and meet the evolving wants and expectations of their prospects. One of the distinguished use circumstances that has emerged is Digital Health, and nations like India, that boast of satisfactory expert expertise swimming pools are being scouted for organising GCCs. Add to this the curiosity proven by Investors, Enterprises, and Hyperscalers, who’re actively engaged or exploring potential engagements with new-age Healthcare start-ups, the Healthcare trade is present process a metamorphosis. Additionally, prior to now few years, Biotechnology, Medical Devices, and Therapeutics have seen a substantial improve in investments.

In this version of the report, we additionally break down case research from the distinguished sub-verticals – Healthcare, Pharmaceuticals, Medical Devices, and Biotechnology. These present an in depth view of the center set up targets, methods, and outcomes of firms like Siemens Healthineers, AstraZeneca, Novartis, and extra.  

Some highlights from this version of the report:

  • There are 1510+ GCCs in India, as of September 2022.
  • Across these, there may be 1.38 Mn whole put in GCC expertise.
  • Bangalore continues to stay as the highest vacation spot for firms to arrange their facilities in India, with 9 new GCCs arrange in Q3 of 2022.
  • In Q3 2022, 15 new GCCs had been arrange in India.
  • ~85% of the whole GCCs established, are in Bangalore, Mumbai, NCR, and Hyderabad.
  • 55%+ of the whole Healthcare & Pharmaceutical GCCs in India are US-headquartered.

Here are another themes that we cowl on this version of the GCC Trends – Quarterly Analysis Q3 2022:

  • Details of all of the GCCs established in India through the 3rd quarter of this 12 months
  • Centers which have expanded throughout the nation
  • Location and vertical-wise mapping of the brand new GCCs established in India in Q3 2022
  • Key themes driving India’s management within the GCC ecosystem
  • Insights on the rise and decline of the choice for Tier II Indian cities for the organising of GCCs
  • The key themes which are driving India’s management within the GCC ecosystem

Please click on the picture to view the complete examine.

NASSCOM-Zinnov India GCC Trends - Quarterly Analysis Q3CY 2022

Speak with our consultants

[adinserter block=”4″]

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here